Alzheimer's disease (AD) is still one of the most difficult diseases to diagnose. The diagnosis is based on a mental state assessment and complementary exams can be ordered, but are usually not enough to be conclusive. A new PET tracer has the possibility to change that. The first-and-only FDA-approved diagnostic PET tracer for estimation of beta-amyloid neuritic plaque density when evaluating for AD and other causes of cognitive decline. In Europe, it will also be available in the second-quarter of this year. This tracer can be seen as an evolution of 11C-PIB, as can be read here.
http://jama.jamanetwork.com/article.aspx?articleid=645188
Official webpage: http://www.amyvid.com/Pages/index.aspx
Why early diagnosis is important? http://www.alz.org/research/science/earlier_alzheimers_diagnosis.asp
This post is really true about the importance of early detection of Alzheimer’s disease and how it can change the life of the patient and the family.
ReplyDeleteAlzheimer’s clinic
Thank you for your comment. My feeling is that people are looking for Alzheimer's treatment and forget how important it is to diagnose it correctly and as early as possible.
DeleteI checked your clinic's webpage. I specially liked:
http://www.agemattersclinic.com/Biomarker-Development.php
Maybe it is time that I write a post about Alzheimer's diagnosis with MRI.